APO AB 300 (Abacavir sulfate 300 mg (base))
This pill with imprint "APO AB 300" is Yellow, Capsule-shape and has been identified as Abacavir sulfate 300 mg (base). It is supplied by Apotex Corp.
Abacavir is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
Abacavir sulfate
- Imprint:
- APO AB 300
- Strength:
- 300 mg (base)
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Apotex Corp
- Inactive Ingredients:
- silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
hypromelloses
polyethylene glycol 8000
ferric oxide yellow
croscarmellose sodium
titanium dioxide
Note: Inactive ingredients may vary.
Imprint Code FAQ's
Other Labelers / Repackagers:| NDC Code | Labeler / Repackager |
|---|---|
| 00904-6523 | Major Pharmaceuticals |
More about abacavir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
Other brands: Ziagen
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
